Employees: 12 (2023.0)Legal category: 5785Size: PMECreation date: 2023-09-18 (2 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINTE-SUZANNE (97441), La Reunion
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE GRAND EST : revenue, balance sheet and financial ratios
PHARMACIE GRAND EST is a French company
founded 2 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINTE-SUZANNE (97441),
this company of category PME
shows in 2024 a net income positive of 583 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE GRAND EST (SIREN 979676442)
Indicator
2024
Revenue
N/C
Net income
583 472 €
EBITDA
N/C
Net margin
N/C
Revenue and income statement
In 2024, PHARMACIE GRAND EST generates positive net income of 583 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
583 472 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 6%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 80%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
6.386%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
79.718%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2024
Debt ratio
6.386
Financial autonomy
79.718
Repayment capacity
None
Cash flow / Revenue
None%
Sector positioning
Debt ratio
6.392024
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Excellent
In 2024, the debt ratio of PHARMACIE GRAND EST (6.39) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
79.72%2024
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent
In 2024, the financial autonomy of PHARMACIE GRAND EST (79.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 186.73. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
186.726
Liquidity indicators evolution PHARMACIE GRAND EST
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2024
Liquidity ratio
186.726
Interest coverage
None
Sector positioning
Liquidity ratio
186.732024
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good
In 2024, the liquidity ratio of PHARMACIE GRAND EST (186.73) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE GRAND EST in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE GRAND EST is estimated at
8 145 700 €
(range 5 672 537€ - 12 186 433€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
5672k€8145k€12186k€
8 145 700 €Range: 5 672 537€ - 12 186 433€
NAF 5 année 2024
Valuation method used
Net Income Multiple
583 472 €
×
14.0x
=8 145 700 €
Range: 5 672 537€ - 12 186 434€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE GRAND EST with other companies in the same sector:
Frequently asked questions about PHARMACIE GRAND EST
What is the revenue of PHARMACIE GRAND EST ?
The revenue of PHARMACIE GRAND EST is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE GRAND EST profitable?
Yes, PHARMACIE GRAND EST generated a net profit of 583 k€ in 2024.
Where is the headquarters of PHARMACIE GRAND EST ?
The headquarters of PHARMACIE GRAND EST is located in SAINTE-SUZANNE (97441), in the department La Reunion.
Where to find the tax return of PHARMACIE GRAND EST ?
The tax return of PHARMACIE GRAND EST is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE GRAND EST operate?
PHARMACIE GRAND EST operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart